254 related articles for article (PubMed ID: 24899720)
1. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
[TBL] [Abstract][Full Text] [Related]
2. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
Caccamo A; Belfiore R; Oddo S
Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
[TBL] [Abstract][Full Text] [Related]
3. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.
Caccamo A; Maldonado MA; Majumder S; Medina DX; Holbein W; Magrà A; Oddo S
J Biol Chem; 2011 Mar; 286(11):8924-32. PubMed ID: 21266573
[TBL] [Abstract][Full Text] [Related]
4. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling and Alzheimer's disease: What we know and where we are?
Davoody S; Asgari Taei A; Khodabakhsh P; Dargahi L
CNS Neurosci Ther; 2024 Apr; 30(4):e14463. PubMed ID: 37721413
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology.
Orr ME; Salinas A; Buffenstein R; Oddo S
Neurobiol Aging; 2014 Jun; 35(6):1233-42. PubMed ID: 24411482
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease.
Pierce A; Podlutskaya N; Halloran JJ; Hussong SA; Lin PY; Burbank R; Hart MJ; Galvan V
J Neurochem; 2013 Mar; 124(6):880-93. PubMed ID: 23121022
[TBL] [Abstract][Full Text] [Related]
9. Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
Al Rihani SB; Lan RS; Kaddoumi A
J Alzheimers Dis; 2019; 72(4):1097-1117. PubMed ID: 31683487
[TBL] [Abstract][Full Text] [Related]
10. The role of mTOR signaling in Alzheimer disease.
Oddo S
Front Biosci (Schol Ed); 2012 Jan; 4(3):941-52. PubMed ID: 22202101
[TBL] [Abstract][Full Text] [Related]
11. A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model.
George AJ; Gordon L; Beissbarth T; Koukoulas I; Holsinger RM; Perreau V; Cappai R; Tan SS; Masters CL; Scott HS; Li QX
Neurotox Res; 2010 May; 17(4):360-79. PubMed ID: 19760337
[TBL] [Abstract][Full Text] [Related]
12. mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.
Perluigi M; Di Domenico F; Barone E; Butterfield DA
Free Radic Biol Med; 2021 Jun; 169():382-396. PubMed ID: 33933601
[TBL] [Abstract][Full Text] [Related]
13. mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging.
Van Skike CE; Lin AL; Roberts Burbank R; Halloran JJ; Hernandez SF; Cuvillier J; Soto VY; Hussong SA; Jahrling JB; Javors MA; Hart MJ; Fischer KE; Austad SN; Galvan V
Aging Cell; 2020 Jan; 19(1):e13057. PubMed ID: 31693798
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer's disease.
Van Skike CE; DeRosa N; Galvan V; Hussong SA
Geroscience; 2023 Jun; 45(3):1987-1996. PubMed ID: 37052770
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathway cross talk in Alzheimer's disease.
Godoy JA; Rios JA; Zolezzi JM; Braidy N; Inestrosa NC
Cell Commun Signal; 2014 Mar; 12():23. PubMed ID: 24679124
[TBL] [Abstract][Full Text] [Related]
16. Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.
Guo J; Cheng J; North BJ; Wei W
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):341-358. PubMed ID: 28694093
[TBL] [Abstract][Full Text] [Related]
17. Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.
Liang H; Nie J; Van Skike CE; Valentine JM; Orr ME
Adv Exp Med Biol; 2019; 1128():185-225. PubMed ID: 31062331
[TBL] [Abstract][Full Text] [Related]
18. Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease.
Xue X; Wang LR; Sato Y; Jiang Y; Berg M; Yang DS; Nixon RA; Liang XJ
Nano Lett; 2014 Sep; 14(9):5110-7. PubMed ID: 25115676
[TBL] [Abstract][Full Text] [Related]
19. Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
de la Monte SM
J Alzheimers Dis; 2023; 95(4):1301-1337. PubMed ID: 37718817
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
Maiese K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
